Clinical Trial Update: A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Nexium (esomeprazole) 20–40 mg daily to ranitidine for healing NSAID-associated gastric ulcers when NSAIDs are continued; trial complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nsaid-associated Gastric Ulcers

Drugs mentioned

• Nexium (esomeprazole)
• Ranitidine (Ranitidine)

Snippet

Sponsor: AstraZeneca | Conditions: NSAID Associated Gastric Ulcers | Phase 3 | Status: COMPLETED